1
Gregory L. Holmes is in the Section of Neurology, Neuroscience Center at Dartmouth, Dartmouth Medical School, Lebanon, New-Hampshire 03756, USA
2
Yezekiel Ben-Ari is at INMED/ INSERM U29, 163 Route de Luminy, 13273 Marseille, cedex 09, France gregory.l.holmes@dartmouth.edu
Epilepsy remains a hard-to-treat disorder for millions of patients. Gene therapy to target brain regions with seizure-reducing compounds is one approach that has met with limited experimental success. An innovative form of genetic manipulation now reduces seizure susceptibility and seizure-induced brain injury in rats (pages 1076−1080).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
